These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28947296)

  • 1. Home-based contact immunotherapy with diphenylcyclopropenone for alopecia areata is as effective and safe as clinic-based treatment in patients with stable disease: A retrospective study of 40 patients.
    Lee S; Lee WS
    J Am Acad Dermatol; 2018 Mar; 78(3):599-601.e1. PubMed ID: 28947296
    [No Abstract]   [Full Text] [Related]  

  • 2. Possible advantage of imiquimod and diphenylcyclopropenone combined treatment versus diphenylcyclopropenone alone: An observational study of nonresponder patients with alopecia areata.
    Wasyłyszyn T; Borowska K
    Australas J Dermatol; 2017 Aug; 58(3):219-223. PubMed ID: 27087586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complex Interaction Between Diphenylcyclopropenone and Immune Responses in Alopecia Areata.
    Tavakolpour S; Mahmoudi HR; Daneshpazhooh M; Rahimzadeh G
    Scand J Immunol; 2016 Nov; 84(5):310-311. PubMed ID: 27500683
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy of alopecia areata with diphenylcyclopropenone].
    Kietzmann H; Hardung H; Christophers E
    Hautarzt; 1985 Jun; 36(6):331-5. PubMed ID: 3160683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical immunotherapy with diphenylcyclopropenone in the treatment of chronic extensive alopecia areata.
    Sotiriadis D; Patsatsi A; Lazaridou E; Kastanis A; Vakirlis E; Chrysomallis F
    Clin Exp Dermatol; 2007 Jan; 32(1):48-51. PubMed ID: 17004987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Home-based diphenylcyclopropenone immunotherapy for alopecia areata: A large retrospective study of 94 cases.
    Nam KH; Lee GJ; Kim JI; Song KH; Park J
    J Dermatol; 2023 Aug; 50(8):1093-1095. PubMed ID: 37334761
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and safety of diphenylcyclopropenone alone or in combination with anthralin in the treatment of chronic extensive alopecia areata: a retrospective case series.
    Durdu M; Özcan D; Baba M; Seçkin D
    J Am Acad Dermatol; 2015 Apr; 72(4):640-50. PubMed ID: 25653027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical immunotherapy with diphenylcyclopropenone-induced vitiligo.
    Kutlubay Z; Engin B; Songur A; Serdaroglu S; Tuzun Y
    J Cosmet Laser Ther; 2016 Aug; 18(4):245-6. PubMed ID: 26963903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Efficacy of Diphenylcyclopropenone in Alopecia Areata: Retrospective Data Analysis of 50 Patients.
    Chiang KS; Mesinkovska NA; Piliang MP; Bergfeld WF
    J Investig Dermatol Symp Proc; 2015 Nov; 17(2):50-5. PubMed ID: 26551948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diphenylcyclopropenone (diphencyprone, DPCP) in the treatment of chronic severe alopecia areata (AA).
    Galadari I; Rubaie S; Alkaabi J; Galadari H
    Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):397-401. PubMed ID: 14768526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired hair curling after diphenylcyclopropenone immunotherapy in alopecia areata patient.
    Choe SJ; Kim BJ; Choi J; Lee WS
    J Eur Acad Dermatol Venereol; 2017 Aug; 31(8):e371-e372. PubMed ID: 28191673
    [No Abstract]   [Full Text] [Related]  

  • 12. Erythema Multiforme Major After Immunotherapy With Diphenylcyclopropenone for Alopecia Areata.
    Sanger J; Zahir A; Driscoll M; Gaspari AA
    Dermatitis; 2018; 29(6):348-349. PubMed ID: 30346328
    [No Abstract]   [Full Text] [Related]  

  • 13. Age dependence of diphenylcyclopropenone sensitization in patients with alopecia areata.
    Temesvári E; González R; Marschalkó M; Horváth A
    Contact Dermatitis; 2004 Jun; 50(6):381-2. PubMed ID: 15274737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Home-based contact immunotherapy with diphenylcyclopropenone improves compliance with the recommended follow-up for patients with alopecia areata: A retrospective cohort study.
    Kim BJ; Lee S; Lee CH; Lee WS
    J Am Acad Dermatol; 2020 May; 82(5):1223-1225. PubMed ID: 31678469
    [No Abstract]   [Full Text] [Related]  

  • 15. Chinese experience in the treatment of alopecia areata with diphenylcyclopropenone.
    Pan R; Liu J; Xuan X; Li B
    J Dermatol; 2015 Feb; 42(2):220-1. PubMed ID: 25545114
    [No Abstract]   [Full Text] [Related]  

  • 16. Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone: evaluation of 68 cases.
    Pericin M; Trüeb RM
    Dermatology; 1998; 196(4):418-21. PubMed ID: 9669118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DPCP for the treatment of alopecia areata.
    Bolduc C; Shapiro J
    Skin Therapy Lett; 2000; 5(5):3-4. PubMed ID: 10854342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical immunotherapy with diphenylcyclopropenone in patients with alopecia areata: A large retrospective study of 757 patients.
    Nasimi M; Abedini R; Ghandi N; Seirafi H; Mehdizade MS; Tootoonchi N
    Dermatol Ther; 2020 Nov; 33(6):e13808. PubMed ID: 32530566
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapy of alopecia areata with diphenylcyclopropenone].
    Ochsendorf FR; Mitrou G; Milbradt R
    Z Hautkr; 1988 Feb; 63(2):94, 96, 99-100. PubMed ID: 3376515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): experience in an Iranian population.
    Aghaei S
    BMC Dermatol; 2005 May; 5():6. PubMed ID: 15918897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.